{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:13:25Z","timestamp":1784981605078,"version":"3.55.0"},"reference-count":106,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sapienza University","award":["RM11715C77336E99"],"award-info":[{"award-number":["RM11715C77336E99"]}]},{"name":"Sapienza University","award":["RG11916B87F55459"],"award-info":[{"award-number":["RG11916B87F55459"]}]},{"name":"Sapienza University","award":["RM11916B84D24429"],"award-info":[{"award-number":["RM11916B84D24429"]}]},{"name":"Sapienza University","award":["RG12117A8697DCF1"],"award-info":[{"award-number":["RG12117A8697DCF1"]}]},{"name":"Sapienza University","award":["952455"],"award-info":[{"award-number":["952455"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["RM11715C77336E99"],"award-info":[{"award-number":["RM11715C77336E99"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["RG11916B87F55459"],"award-info":[{"award-number":["RG11916B87F55459"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["RM11916B84D24429"],"award-info":[{"award-number":["RM11916B84D24429"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["RG12117A8697DCF1"],"award-info":[{"award-number":["RG12117A8697DCF1"]}]},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program","award":["952455"],"award-info":[{"award-number":["952455"]}]},{"name":"Italian Ministry of Health \u201cRicerca corrente\u201d","award":["RM11715C77336E99"],"award-info":[{"award-number":["RM11715C77336E99"]}]},{"name":"Italian Ministry of Health \u201cRicerca corrente\u201d","award":["RG11916B87F55459"],"award-info":[{"award-number":["RG11916B87F55459"]}]},{"name":"Italian Ministry of Health \u201cRicerca corrente\u201d","award":["RM11916B84D24429"],"award-info":[{"award-number":["RM11916B84D24429"]}]},{"name":"Italian Ministry of Health \u201cRicerca corrente\u201d","award":["RG12117A8697DCF1"],"award-info":[{"award-number":["RG12117A8697DCF1"]}]},{"name":"Italian Ministry of Health \u201cRicerca corrente\u201d","award":["952455"],"award-info":[{"award-number":["952455"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Down syndrome (DS) is the most frequent genetic cause of intellectual disability and is strongly associated with Alzheimer\u2019s disease (AD). Brain insulin resistance greatly contributes to AD development in the general population and previous studies from our group showed an early accumulation of insulin resistance markers in DS brain, already in childhood, and even before AD onset. Here we tested the effects promoted in Ts2Cje mice by the intranasal administration of the KYCCSRK peptide known to foster insulin signaling activation by directly interacting and activating the insulin receptor (IR) and the AKT protein. Therefore, the KYCCSRK peptide might represent a promising molecule to overcome insulin resistance. Our results show that KYCCSRK rescued insulin signaling activation, increased mitochondrial complexes levels (OXPHOS) and reduced oxidative stress levels in the brain of Ts2Cje mice. Moreover, we uncovered novel characteristics of the KYCCSRK peptide, including its efficacy in reducing DYRK1A (triplicated in DS) and BACE1 protein levels, which resulted in reduced AD-like neuropathology in Ts2Cje mice. Finally, the peptide elicited neuroprotective effects by ameliorating synaptic plasticity mechanisms that are altered in DS due to the imbalance between inhibitory vs. excitatory currents. Overall, our results represent a step forward in searching for new molecules useful to reduce intellectual disability and counteract AD development in DS.<\/jats:p>","DOI":"10.3390\/antiox12010111","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T04:17:38Z","timestamp":1672633058000},"page":"111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer\u2019s Disease-like Neuropathology in a Mouse Model for Down Syndrome"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-2086","authenticated-orcid":false,"given":"Antonella","family":"Tramutola","sequence":"first","affiliation":[{"name":"Department of Biochemical Sciences \u201cA. Rossi-Fanelli\u201d, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8421-023X","authenticated-orcid":false,"given":"Simona","family":"Lanzillotta","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences \u201cA. Rossi-Fanelli\u201d, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7530-6835","authenticated-orcid":false,"given":"Giuseppe","family":"Aceto","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pagnotta","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences \u201cA. Rossi-Fanelli\u201d, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-5496","authenticated-orcid":false,"given":"Gabriele","family":"Ruffolo","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, 00185 Rome, Italy"},{"name":"IRCCS San Raffaele Roma, 00163 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Cifelli","sequence":"additional","affiliation":[{"name":"Department of Applied Clinical and Biotechnological Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-1117","authenticated-orcid":false,"given":"Federico","family":"Marini","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5315-0163","authenticated-orcid":false,"given":"Cristian","family":"Ripoli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-927X","authenticated-orcid":false,"given":"Eleonora","family":"Palma","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome Sapienza, 00185 Rome, Italy"},{"name":"IRCCS San Raffaele Roma, 00163 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-1685","authenticated-orcid":false,"given":"Claudio","family":"Grassi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-209X","authenticated-orcid":false,"given":"Fabio","family":"Di Domenico","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences \u201cA. Rossi-Fanelli\u201d, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Perluigi","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences \u201cA. Rossi-Fanelli\u201d, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-4251","authenticated-orcid":false,"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[{"name":"Department of Biochemical Sciences \u201cA. Rossi-Fanelli\u201d, Sapienza University of Rome, Piazzale A. Moro 5, 00185 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer\u2019s disease associated with Down syndrome: A genetic form of dementia","volume":"20","author":"Fortea","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0074-7750(10)39004-5","article-title":"Health conditions associated with aging and end of life of adults with Down syndrome","volume":"39","author":"Esbensen","year":"2010","journal-title":"Int. Rev. Res. Ment. Retard."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Karmiloff-Smith, A., Al-Janabi, T., D\u2019Souza, H., Groet, J., Massand, E., Mok, K., Startin, C., Fisher, E., Hardy, J., and Nizetic, D. (2016). The importance of understanding individual differences in Down syndrome. F1000Research, 5.","DOI":"10.12688\/f1000research.7506.1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fnins.2020.00670","article-title":"Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions","volume":"14","author":"Dierssen","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Moreau, M., Benhaddou, S., Dard, R., Tolu, S., Hamze, R., Vialard, F., Movassat, J., and Janel, N. (2021). Metabolic Diseases and Down Syndrome: How Are They Linked Together?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020221"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/js.2017-00044","article-title":"Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study","volume":"1","author":"Abbasi","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ridd.2016.06.018","article-title":"Overweight and obesity in children and adolescents with Down syndrome-prevalence, determinants, consequences, and interventions: A literature review","volume":"57","author":"Bertapelli","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2021.09.006","article-title":"The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease","volume":"176","author":"Barone","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2017.08.024","article-title":"Clinical aspects and biomarkers of Alzheimer\u2019s disease in Down syndrome","volume":"114","author":"Zis","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Burillo, J., Marques, P., Jimenez, B., Gonzalez-Blanco, C., Benito, M., and Guillen, C. (2021). Insulin Resistance and Diabetes Mellitus in Alzheimer\u2019s Disease. Cells, 10.","DOI":"10.3390\/cells10051236"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","article-title":"Impaired insulin signalling and allostatic load in Alzheimer disease","volume":"23","author":"Goncalves","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J. Neural Transm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014Is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): Analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamaneurol.2019.2462","article-title":"Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging","volume":"76","author":"Kapogiannis","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/alz.12499","article-title":"Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles","volume":"18","author":"Perluigi","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/1673-5374.317979","article-title":"Brain insulin resistance: An early risk factor for Alzheimer\u2019s disease development in Down syndrome","volume":"17","author":"Barone","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2021.01.042","article-title":"Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome","volume":"165","author":"Lanzillotta","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104772","DOI":"10.1016\/j.nbd.2020.104772","article-title":"Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome","volume":"137","author":"Tramutola","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13543784.2022.2022122","article-title":"New treatment approaches for Alzheimer\u2019s disease: Preclinical studies and clinical trials centered on antidiabetic drugs","volume":"31","author":"Katsenos","year":"2022","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"708547","DOI":"10.3389\/fnins.2021.708547","article-title":"Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus","volume":"15","author":"Sim","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s13760-022-01907-2","article-title":"Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer\u2019s disease neuropathology","volume":"122","author":"Yang","year":"2022","journal-title":"Acta Neurol. Belg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s12035-018-1231-5","article-title":"Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease","volume":"56","author":"Barone","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000510677","article-title":"Antidiabetic Drugs in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Systematic Review","volume":"49","author":"Zaarkti","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-007-9643-y","article-title":"The protective role of carotenoids against 7-keto-cholesterol formation in solution","volume":"309","author":"Palozza","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11481-006-9039-x","article-title":"Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS","volume":"2","author":"Hanson","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41598-022-05165-3","article-title":"Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer\u2019s disease: A randomized trial","volume":"12","author":"Kellar","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_32","first-page":"240","article-title":"Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"8","author":"Kellar","year":"2021","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40268-020-00296-2","article-title":"Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome","volume":"20","author":"Rosenbloom","year":"2020","journal-title":"Drugs R D"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4155\/tde.13.5","article-title":"Peptide pills for brain diseases? Reality and future perspectives","volume":"4","author":"Lalatsa","year":"2013","journal-title":"Ther. Deliv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: Current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.13-247015","article-title":"Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor","volume":"28","author":"Gibbs","year":"2014","journal-title":"FASEB J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4712053","DOI":"10.1155\/2016\/4712053","article-title":"Nanoparticle Delivered Human Biliverdin Reductase-Based Peptide Increases Glucose Uptake by Activating IRK\/Akt\/GSK3 Axis: The Peptide Is Effective in the Cell and Wild-Type and Diabetic Ob\/Ob Mice","volume":"2016","author":"Gibbs","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tips.2008.12.003","article-title":"Pleiotropic functions of biliverdin reductase: Cellular signaling and generation of cytoprotective and cytotoxic bilirubin","volume":"30","author":"Kapitulnik","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cimini, F.A., Perluigi, M., Barchetta, I., Cavallo, M.G., and Barone, E. (2022). Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105574"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm. Genome"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13238","DOI":"10.1073\/pnas.192445299","article-title":"Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes","volume":"99","author":"Miledi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pneurobio.2009.01.008","article-title":"Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: A potent tool for expanding functional information","volume":"88","author":"Eusebi","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions","volume":"95","author":"Ruffolo","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","article-title":"Insulin action in the brain: Cell types, circuits, and diseases","volume":"45","author":"Chen","year":"2022","journal-title":"Trends Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1092952","article-title":"Insulin signaling in health and disease","volume":"302","author":"White","year":"2003","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI113711","article-title":"The insulin receptor and the molecular mechanism of insulin action","volume":"82","author":"Kahn","year":"1988","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2019.02.003","article-title":"Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer\u2019s disease","volume":"125","author":"Sharma","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.bbadis.2018.07.005","article-title":"Biliverdin reductase-A impairment links brain insulin resistance with increased Abeta production in an animal model of aging: Implications for Alzheimer disease","volume":"1864","author":"Triani","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"104739","DOI":"10.1016\/j.nbd.2020.104739","article-title":"Insulin deficiency promotes formation of toxic amyloid-beta42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer\u2019s disease model","volume":"137","author":"Imamura","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","article-title":"Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain","volume":"1842","author":"Butterfield","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fnins.2019.00788","article-title":"Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline","volume":"13","author":"Spinelli","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/alz.12130","article-title":"Extracellular vesicle biomarkers of Alzheimer\u2019s disease associated with sub-clinical cognitive decline in late middle age","volume":"16","author":"Eren","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11597760-000000000-00000","article-title":"Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer\u2019s disease","volume":"72","year":"2012","journal-title":"Drugs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"le3","DOI":"10.1074\/jbc.L110.133520","article-title":"Curcumin and Alzheimer disease: This marriage is not to be performed","volume":"286","author":"Mancuso","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/alz.12463","article-title":"Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model","volume":"18","author":"Sawa","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1523\/JNEUROSCI.0578-19.2019","article-title":"Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-betaCTF (C99)","volume":"39","author":"Jiang","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neurobiolaging.2015.11.013","article-title":"Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: Role of APP-CTF","volume":"39","author":"Jiang","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"700280","DOI":"10.3389\/fnagi.2021.700280","article-title":"Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome","volume":"13","author":"Chen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1038\/s41598-017-07544-7","article-title":"Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer\u2019s Disease-like Neurotoxicity","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/acel.12498","article-title":"Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe\/PS1dE9 mice","volume":"15","author":"Mao","year":"2016","journal-title":"Aging Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40266-013-0099-3","article-title":"BACE1 as a therapeutic target in Alzheimer\u2019s disease: Rationale and current status","volume":"30","author":"Evin","year":"2013","journal-title":"Drugs Aging"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41467-018-03755-2","article-title":"The beta secretase BACE1 regulates the expression of insulin receptor in the liver","volume":"9","author":"Meakin","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"909669","DOI":"10.3389\/fnins.2022.909669","article-title":"Rodent Modeling of Alzheimer\u2019s Disease in Down Syndrome: In vivo and ex vivo Approaches","volume":"16","author":"Farrell","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"dmm031013","DOI":"10.1242\/dmm.031013","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of Down syndrome","volume":"11","author":"Aziz","year":"2018","journal-title":"Dis. Model Mech."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: Impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model Mech."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","article-title":"The role of DYRK1A in neurodegenerative diseases","volume":"278","author":"Wegiel","year":"2011","journal-title":"FEBS J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: A lifelong relationship","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","article-title":"Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models","volume":"20","author":"Ferrer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Atas-Ozcan, H., Brault, V., Duchon, A., and Herault, Y. (2021). Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. Genes, 12.","DOI":"10.3390\/genes12111833"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4161\/cc.29250","article-title":"Dyrk1A induces pancreatic beta cell mass expansion and improves glucose tolerance","volume":"13","author":"Rachdi","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dbi16-0013","article-title":"DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies","volume":"65","author":"Belgardt","year":"2016","journal-title":"Diabetes"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/acs.jmedchem.9b01624","article-title":"Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20140772","article-title":"Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: Overlaps in Down\u2019s syndrome and Alzheimer\u2019s disease brain","volume":"463","author":"Butterfield","year":"2014","journal-title":"Biochem. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbadis.2011.10.001","article-title":"Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome","volume":"1822","author":"Cenini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mito.2022.05.007","article-title":"Triplication of HSA21 on alterations in structure and function of mitochondria","volume":"65","author":"Ganguly","year":"2022","journal-title":"Mitochondrion"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Conti, A., Fabbrini, F., D\u2019Agostino, P., Negri, R., Greco, D., Genesio, R., D\u2019Armiento, M., Olla, C., Paladini, D., and Zannini, M. (2007). Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genom., 8.","DOI":"10.1186\/1471-2164-8-268"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/hmg\/dds529","article-title":"Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects","volume":"22","author":"Piccoli","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Fujimaki, S., and Kuwabara, T. (2017). Diabetes-Induced Dysfunction of Mitochondria and Stem Cells in Skeletal Muscle and the Nervous System. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102147"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-94-007-2869-1_10","article-title":"Mitochondria and diabetes. An intriguing pathogenetic role","volume":"942","author":"Newsholme","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmet.2018.01.013","article-title":"Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-beta uptake in astrocytes","volume":"9","author":"Logan","year":"2018","journal-title":"Mol. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2007-1190","article-title":"Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats","volume":"149","author":"Delgado","year":"2008","journal-title":"Endocrinology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2174\/092986707781058968","article-title":"Mechanistic insights into diabetes mellitus and oxidative stress","volume":"14","author":"Maiese","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/156720207779940653","article-title":"Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus","volume":"4","author":"Maiese","year":"2007","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lfs.2012.08.017","article-title":"Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats","volume":"91","author":"Pintana","year":"2012","journal-title":"Life Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/dmrr.579","article-title":"Oxidative damage in cerebral vessels of diabetic db\/db mice","volume":"21","author":"Liao","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2337\/db11-1186","article-title":"Metabolic alterations induced by sucrose intake and Alzheimer\u2019s disease promote similar brain mitochondrial abnormalities","volume":"61","author":"Carvalho","year":"2012","journal-title":"Diabetes"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1096\/fj.201802043R","article-title":"Insulin deficiency and intranasal insulin alter brain mitochondrial function: A potential factor for dementia in diabetes","volume":"33","author":"Ruegsegger","year":"2019","journal-title":"FASEB J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: Molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"657928","DOI":"10.1155\/2015\/657928","article-title":"Modulation of hippocampal neural plasticity by glucose-related signaling","volume":"2015","author":"Mainardi","year":"2015","journal-title":"Neural Plast."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e58731","DOI":"10.7554\/eLife.58731","article-title":"Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome","volume":"9","author":"Donato","year":"2020","journal-title":"eLife"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fncel.2017.00054","article-title":"The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome","volume":"11","author":"Contestabile","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fncel.2018.00362","article-title":"The Regulation of AMPA Receptor Endocytosis by Dynamic Protein-Protein Interactions","volume":"12","author":"Hanley","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","article-title":"The AMPA Receptor Code of Synaptic Plasticity","volume":"100","author":"Diering","year":"2018","journal-title":"Neuron"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.12.001","article-title":"Insulin-mediated synaptic plasticity in the CNS: Anatomical, functional and temporal contexts","volume":"136","author":"Ferrario","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Brault, V., Nguyen, T.L., Flores-Gutierrez, J., Iacono, G., Birling, M.C., Lalanne, V., Meziane, H., Manousopoulou, A., Pavlovic, G., and Lindner, L. (2021). Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. PLoS Genet., 17.","DOI":"10.1101\/2021.05.01.442242"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neurom.2021.09.003","article-title":"Synaptic Plasticity 101: The Story of the AMPA Receptor for the Brain Stimulation Practitioner","volume":"25","author":"Brown","year":"2022","journal-title":"Neuromodulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"dmm035634","DOI":"10.1242\/dmm.035634","article-title":"Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A","volume":"11","author":"Nguyen","year":"2018","journal-title":"Dis. Model Mech."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"101162","DOI":"10.1016\/j.redox.2019.101162","article-title":"Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome","volume":"23","author":"Tramutola","year":"2019","journal-title":"Redox Biol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/1\/111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:56:11Z","timestamp":1760118971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/1\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["antiox12010111"],"URL":"https:\/\/doi.org\/10.3390\/antiox12010111","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]}}}